| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/20/2008 | EP1958620A1 Verification method |
| 08/20/2008 | EP1958619A1 Process for producing tablet by high-speed direct compression |
| 08/20/2008 | EP1958618A1 Method for freeze-drying with optimum reconstitution of biopolymers |
| 08/20/2008 | EP1958617A1 Pharmaceutical compositions containing quetiapine fumarate |
| 08/20/2008 | EP1958616A1 Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof |
| 08/20/2008 | EP1958615A1 Solid pharmaceutical formulations of a homogeneous dispersion of active principles having pH-dependent solubility |
| 08/20/2008 | EP1958613A1 Dermal film-forming liquid formulations for drug release to skin |
| 08/20/2008 | EP1957537A2 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 08/20/2008 | EP1957396A1 Nanoporous membrane and method of preparation thereof |
| 08/20/2008 | EP1957190A2 Method and apparatus for forming chromonic nanoparticles |
| 08/20/2008 | EP1957168A2 Glucan compositions |
| 08/20/2008 | EP1957137A2 Inhaler and store for a dry medicament formulation and related methods and use thereof |
| 08/20/2008 | EP1957121A2 Acute treatment of social phobia |
| 08/20/2008 | EP1957113A2 Polymer particles for delivery of macromolecules and methods of use |
| 08/20/2008 | EP1957090A1 Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome |
| 08/20/2008 | EP1957087A1 Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases |
| 08/20/2008 | EP1957081A1 Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid |
| 08/20/2008 | EP1957080A2 Topical glucocorticosteroid formulations |
| 08/20/2008 | EP1957071A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 08/20/2008 | EP1957070A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 08/20/2008 | EP1957055A2 Patch |
| 08/20/2008 | EP1957054A2 Fast-acting oral peptide pharmaceutical products |
| 08/20/2008 | EP1957053A2 Biocompatible latent emulsifiers |
| 08/20/2008 | EP1957052A2 A gastric retention drug delivery system |
| 08/20/2008 | EP1957051A1 Intraorally rapidly disintegrating tablet |
| 08/20/2008 | EP1957050A2 Polypeptide films and methods |
| 08/20/2008 | EP1957049A1 Granular, gastro-resistant product based on niacin or derivates thereof and process for the production of such a product |
| 08/20/2008 | EP1957048A2 Solid orally administerable pharmaceutical dosage forms with rapid active principle release |
| 08/20/2008 | EP1957047A2 Methods of stabilizing unconsolidated subterranean formations |
| 08/20/2008 | EP1957046A1 Orally administrable extended release pellet and tablet formulations of a highly water soluble compound |
| 08/20/2008 | EP1957045A2 Bioactive fus1 peptides and nanoprticle-polypeptide complexes |
| 08/20/2008 | EP1957044A2 Amphoteric liposome formulation |
| 08/20/2008 | EP1957043A2 Aerosol formulation for inhalation containing an anticholinergic agent |
| 08/20/2008 | EP1957042A2 Aerosol formulation for inhalation containing an anticholinergic agent |
| 08/20/2008 | EP1957041A1 Oil-in-water emulsion and its use for the delivery of functionality |
| 08/20/2008 | EP1957040A2 Benzimidazole non-aqueous compositions |
| 08/20/2008 | EP1957039A2 Intravenous essential fatty acid emulsion |
| 08/20/2008 | EP1957038A2 Particles |
| 08/20/2008 | EP1957037A1 Novel pharmaceutical composition consisting of water-soluble or poorly water-soluble active substances |
| 08/20/2008 | EP1956925A2 Base material for producing food and fodder |
| 08/20/2008 | EP1956894A2 Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent |
| 08/20/2008 | EP1750679B1 Gel composition comprising charged polymers |
| 08/20/2008 | EP1746977A4 Active drug delivery in the gastrointestinal tract |
| 08/20/2008 | EP1648517B1 Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
| 08/20/2008 | EP1646366A4 Method of preparing mixed formulation of sustained release microspheres by continuous one-step process |
| 08/20/2008 | EP1613371B1 A device, cartridge and method for solving powder in liquid, when manufacturing a dialysis fluid |
| 08/20/2008 | EP1542663B1 A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 08/20/2008 | EP1523336B1 Targeted agents for nerve regeneration |
| 08/20/2008 | EP1509223B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/20/2008 | EP1509205B1 Pharmaceutical composition having a delayed active substance release and method for the preparation thereof |
| 08/20/2008 | EP1502020B1 Stackable low depth tray |
| 08/20/2008 | EP1428530B1 Tetrapeptide derivative crystals |
| 08/20/2008 | EP1339389B1 Compositions for sustained delivery of hydrophobic drugs and process for the preparation thereof |
| 08/20/2008 | EP1331902B1 Improved ophthalmic and contact lens solutions containing forms of vitamin b |
| 08/20/2008 | EP1282429B1 Pharmaceutical gel composition |
| 08/20/2008 | EP1268626B1 Porous polymer vesicle and a process for the preparation thereof |
| 08/20/2008 | EP1255547B1 Controlled-release compositions containing opioid agonist and antagonist |
| 08/20/2008 | EP1232262B1 Recombinant gelatin in vaccines |
| 08/20/2008 | EP1210947B1 Ophthalmic ointment comprising vancomycin hydrochloride for treating infective eye diseases |
| 08/20/2008 | EP1105111B1 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 08/20/2008 | EP1044017B1 Supplement for dialysis patients |
| 08/20/2008 | CN201101723Y Medicine pillow pad for cervical vertebra |
| 08/20/2008 | CN201101722Y Multi-tier graph plotting type skin pasting cloth |
| 08/20/2008 | CN201101636Y Novel tinea pedis treating pad plaster |
| 08/20/2008 | CN201101634Y Elastic body shaping plaster cloth |
| 08/20/2008 | CN201101612Y Butt plate plaster |
| 08/20/2008 | CN101247836A Nanoparticle active ingredients conjugates |
| 08/20/2008 | CN101247835A Peroxide removal from drug delivery vehicle |
| 08/20/2008 | CN101247805A Tablet containing hardly soluble active ingredient |
| 08/20/2008 | CN101247795A Methods and compositions for treatment of CNS disorders |
| 08/20/2008 | CN101247792A Pharmaceutical compositions comprising a PH-dependent drug, a PH modifier and a retarding agent |
| 08/20/2008 | CN101247791A Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate |
| 08/20/2008 | CN101247790A Drug compositions containing controlled release hypromellose matrices |
| 08/20/2008 | CN101247789A Bioresorbable polymer matrices and methods of making and using the same |
| 08/20/2008 | CN101247788A Fentanyl formulation containing an essential oil |
| 08/20/2008 | CN101247787A Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent |
| 08/20/2008 | CN101247786A Oral suspension of prednisolone acetate |
| 08/20/2008 | CN101244277A Medicine carrying fibroin microsphere and preparation thereof |
| 08/20/2008 | CN101244276A Plant capsule with cellulose vitriolate of soda as principal raw material and preparation method |
| 08/20/2008 | CN101244275A Long-acting sustained-release medicaments for treating and renovating bone disease and preparation thereof |
| 08/20/2008 | CN101244263A Mixture containing mix interferon-alpha hypotype |
| 08/20/2008 | CN101244261A Biological agent containing non-renaturation recombinant protein, preparation method and application thereof |
| 08/20/2008 | CN101244259A Thymus gland peptide alpha1sustained-release microsphere preparation for injection and preparation thereof |
| 08/20/2008 | CN101244258A Use of TAT-N25 polypeptide in treating cell growth exception dermatosis such as psoriasis |
| 08/20/2008 | CN101244256A Micro/sub-micro emulsion in situ gel rubber preparation of cyclosporins A for eyes and preparation thereof |
| 08/20/2008 | CN101244255A Thymus gland pentapeptide injection and uses thereof |
| 08/20/2008 | CN101244252A Chinese medicine label for eliminating ache and preparation thereof |
| 08/20/2008 | CN101244247A Pharmaceutical combination for treating cervical vertebra disease and waist and leg pain, and preparation thereof |
| 08/20/2008 | CN101244246A Chinese medicine composition for treating epilepsy and method of preparing the same |
| 08/20/2008 | CN101244244A Depression treating medicine composition and preparation method thereof |
| 08/20/2008 | CN101244243A Pharmaceutical combination for treating gastritis, preparation method and application thereof |
| 08/20/2008 | CN101244240A Quality control method for four turmeric soup preparations |
| 08/20/2008 | CN101244238A Traditional Chinese medicine composition for treating climacteric syndrome |
| 08/20/2008 | CN101244237A Suppository and preparation thereof |
| 08/20/2008 | CN101244235A Scraping oil, preparation method and application thereof |
| 08/20/2008 | CN101244234A Medicaments for preventing and controlling ischemia and hemorrhagic cerebrovaseular disease, and preparation thereof |
| 08/20/2008 | CN101244230A Quality control method for Chinese medicine compound preparation for treating gastric cavity ache |
| 08/20/2008 | CN101244229A Powder medicine for treating hernia |
| 08/20/2008 | CN101244228A Brazilian mushroom lozenge composition and method of making the same |
| 08/20/2008 | CN101244227A Chinese medicine pill mainly for treating nephropathy and preparation thereof |